Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer

Phase II study; open recruitment, multicentrique. The aim of this clinical research is to evaluate faisability and toxicity of the per-operative radiotherapy using PAPILLON + TM device for localized breast cancers patients over 65 years.

Trial Details

NCT ID
NCT04680715
Phase
PHASE2
Sponsor
Centre Antoine Lacassagne
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Per-Operative Radiotherapy technique by Papillon +TM
Locations (sample)
  • Clermont-Ferrand, France|45.77969,3.08682
  • Nice, France|43.70313,7.26608

Key Eligibility Criteria

  • Patient with invasive ductal adenocarcinoma \<=2cm, evaluate on all radiological exams;
  • Women aged 65 years or older (patients 65 years of age in the year may be included);
  • Grade 1 or 2 unifocal adenocarcinoma, all index KI67, positive HR, negative HER2 status;
  • T0 or T1, N0 radio-clinic;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →